AM2201-d5 (exempt preparation) (Item No. 22870) is intended for use as an internal standard for the quantification of AM2201 (Item Nos. 10707 | 15668) by GC- or LC-MS. AM2201 is categorized as a synthetic cannabinoid.1 AM2201 is regulated as a Schedule I compound in the United States. AM2201-d5 (exempt preparation) (Item No. 22870) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use.
Description
AM2201-d5 (Item No. 10706) is intended for use as an internal standard for the quantification of AM2201 (Item Nos. 10707 | 15668) by GC- or LC-MS. AM2201 is categorized as a synthetic cannabinoid.1 AM2201-d5 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use.
References
[1] A K DUTTA. Synthesis, pharmacology, and molecular modeling of novel 4-alkyloxy indole derivatives related to cannabimimetic aminoalkyl indoles (AAIs).[J]. Bioorganic & Medicinal Chemistry, 1997, 5 8: 1591-1600. DOI: 10.1016/s0968-0896(97)00111-9
PROMPT×
PROMPT
The What'sApp is temporarily not supported in mainland China
